CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
  • US
    • US
    • EUROPE
    • APAC
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of...

Three Steps To Succeed With Digital...

Philippe Caby, CIO, Centrient Pharmaceuticals

Strategies for RIM system Selection when...

Joel Finkle, Associate Director, Regulatory...

How to Manage Regulatory Compliance

Scott Cleve, Vice President Regulatory Operations...

Maintaining Regulatory Impacts

Robyn Meurant, Executive Director, Regulatory...

How Technology is Disrupting the Pharma...

Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc

Specialized Services: A New Paradigm in...

Brian D. Fry, Senior Director, Cell Therapy CDMO,...

Setting A Culture for Digital...

Ross Kenyon, Associate Director – Modeling,...

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of...

Three Steps To Succeed With Digital...

Philippe Caby, CIO, Centrient Pharmaceuticals

Strategies for RIM system Selection when...

Joel Finkle, Associate Director, Regulatory...

How to Manage Regulatory Compliance

Scott Cleve, Vice President Regulatory Operations...

Maintaining Regulatory Impacts

Robyn Meurant, Executive Director, Regulatory...

How Technology is Disrupting the Pharma...

Colin Boatwright, CIO, Ironshore Pharmaceuticals Inc

Specialized Services: A New Paradigm in...

Brian D. Fry, Senior Director, Cell Therapy CDMO,...

Setting A Culture for Digital...

Ross Kenyon, Associate Director – Modeling,...

How Regulatory has Become Strategically Important to Food andFeed Companies

Caroline Herody, Head of Global Regulatory Affairs,Chr. Hansen
Tweet

If you started your career more than 15 years ago, you may remember that most food and feed companies didn’t even have a Regulatory function. Well, now not only most of those companies have created a dedicated department, butwe are invited to provide input to defining the companystrategyand to deciding on whether or not to invest or acquire a new business – Why this transformation?


In the wake of a series of human food and animal feed crises combined with an increasing concern about the risk of consumers being misled, a number of countries decided to initiate substantial reforms of their food law in the early 2000s.  Those set of international, regional and national regulations form a complex system of rules covering the entire food chain, from animal feed and health, through plant protection and food production, to processing, storage, transport, import and export and retail sales.


As outcome-based regulations have been considered appropriate for low to medium risk activities and not high-risk activities such as feeding people and animals, those reforms generally privileged prescriptive regulations which state or describe what must be done and also how work is to be carried out. An increasing number of products entering the food chain have also become subject topre-market approvals based on the assessment of extensive datasets on the identity, safety and efficacy of the product.


In practice, this means that companies operating in the food and feed sector have had to adapt to that fact that conditions for market access of their products have become more demanding and more challenging to implement in their innovation process and supply chain.


Where to play and how to win       


The performance of a Regulatory teamnotonly directly impacts the speed and cost to market of innovations, but also helps mitigatethe risk of market access discontinuity in a context of constant evolution of regulations and standards.


Regulatory is now involved when a company defines it strategy, i.e., when it makes explicit choices on which things to prioritize and then builds a business around those choices.


Where to play represents the set of choices that narrow the competitive field. The questions to be asked focus on where the company will compete— in which markets, with which customers and consumers, through which channels and in which product categories. It could also lead to the decision to acquire or merge with another existing business. The role of Regulatory is to provide insight on the expected time and budget needed to access the selected markets of interest, to estimate the likelihood of success, and also to ensure that coming changes to regulations and standards will not jeopardize access to the market.


“Regulatory is now involved when a company defines it strategy, i.e., when it makes explicit choices on which things to prioritize and then builds a business around those choices.”


How to win defines the choices for winning in that field. It is the recipe for success in the chosen segments, categories, channels, geographies, and so on. It is of utmost importance to anticipate the capabilities, capacity and footprint needed for Regulatory to open the markets within the time and budget forecast in the Strategy.The ability to attractthe best regulatory experts and transforming them into an expert team, combining high level of task-related expertise and the mastering of team processes, will eat your market access strategy for breakfast.


About Chr. Hansen   


Perhaps you have never heard of Chr. Hansen, but chances are you had a bite of us this morning! Founded in 1874, our natural ingredients – good bacteria, probiotics or enzymes – are in every other cheese and yogurt in the world, and we touch the lives of more than one billion people every day. We are present in over 30 countries with 3,700 employees and rank as one of the world’s most sustainable companies.


Weekly Brief

loading
Top 10 Regulatory Services Companies - 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue

Read Also

Specialized Services: A New Paradigm in Therapeutics

Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Ross Kenyon, Associate Director – Modeling, Simulation and Analysis, Regeneron Pharmaceuticals

The 7 TIPS for a Successful Master Data Migration and Ongoing Data Quality Management

Marc Jenny, Senior Director, Customer Engagement Systems & Advanced Analytics Strategy Lead, Interl. & Japan, Alexion Pharmaceuticals

The Challenges Of Bringing Phytocannabinoid Plant-Based Medicines To Market

Ron Lipsky, Vice President, Business Development & International Relations at MGC Pharmaceuticals, Ltd.

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin, Director, Infection Prevention, Tampa General Hospital

Digital Innovation

Iris Loew-Friedrich, EVP & Chief Medical Officer, UCB

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Anders Damholt, PhD Biochemistry, Head of Clinical Development Human Health Innovation & Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist, Human Health Innovation

The Rise in Outsourcing Clinical Trials

Erika Vento-Gaudens, Director, Global Clinical Trial Operations at Guardant Health
Loading...

Copyright © 2022 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://regulatory-services.lifesciencesreview.com/cxoinsight/how-regulatory-has-become-strategically-important-to-food-andfeed-companies-nwid-812.html